Decision issued on US stem cell clinics accused of violating the law
The court held that the defendants adulterated and misbranded a stem cell drug product made from a patient’s adipose tissue.
List view / Grid view
The court held that the defendants adulterated and misbranded a stem cell drug product made from a patient’s adipose tissue.
A new study shows that the growth rate of a tumour does not depend solely on how quickly the cancer cells can divide.
A novel way to create Expanded Potential Stem Cells has generated opportunities to research regenerative medicine.
An international team of researchers has proven that targeting a specific area of the flu virus protects humans.
A study has detailed the change in the gut microbiome, increasing the potential for new IBD therapies.
Using exclusively male animals in experiments biases results, argues Rebecca Shansky.
Nuclear magnetic resonance measurement and state-of-the-art computational science reveal protein structures in higher eukaryotic cells.
Structure of internal regulator molecule identified, presenting lupus drug potential.
Arizona company claims their products can treat Lyme disease, diabetes, Parkinson’s disease and more, but have not been approved for any use.
Researchers succeed in using machine learning to make the mass analysis of proteins faster and almost error-free.
Researchers use high-throughput DNA sequencing technology to identify a potential vaccine target for Strep A.
New research could lead to novel treatments for autoimmune disorders and sheds light on the causes of autoimmunity.
A new signalling protein discovery could lead to drug-based therapies to treat hyperparathyroidism.
A study has identified a molecule which boosts immune cell function and could be used in cancer therapies.
A study has shown that the organisation of the gut is broken into functional compartments, improving opportunities for gastrointestinal disorder drugs and oral vaccines.